Pharmacology and metabolism of infliximab biosimilars – A new treatment option in inflammatory bowel diseases
Publication type: Journal Article
Publication date: 2016-08-01
scimago Q1
wos Q2
SJR: 0.933
CiteScore: 7.7
Impact factor: 3.8
ISSN: 17341140, 22995684
PubMed ID:
27162107
General Medicine
Pharmacology
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
|
|
|
Pharmacological Reports
1 publication, 33.33%
|
|
|
Journal of Ethnopharmacology
1 publication, 33.33%
|
|
|
Cell Biochemistry and Function
1 publication, 33.33%
|
|
|
1
|
Publishers
|
1
|
|
|
Springer Nature
1 publication, 33.33%
|
|
|
Elsevier
1 publication, 33.33%
|
|
|
Wiley
1 publication, 33.33%
|
|
|
1
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
3
Total citations:
3
Citations from 2024:
0
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Włodarczyk M., Fichna J., Sobolewska Włodarczyk A. Pharmacology and metabolism of infliximab biosimilars – A new treatment option in inflammatory bowel diseases // Pharmacological Reports. 2016. Vol. 68. No. 4. pp. 797-801.
GOST all authors (up to 50)
Copy
Włodarczyk M., Fichna J., Sobolewska Włodarczyk A. Pharmacology and metabolism of infliximab biosimilars – A new treatment option in inflammatory bowel diseases // Pharmacological Reports. 2016. Vol. 68. No. 4. pp. 797-801.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.pharep.2016.04.006
UR - https://doi.org/10.1016/j.pharep.2016.04.006
TI - Pharmacology and metabolism of infliximab biosimilars – A new treatment option in inflammatory bowel diseases
T2 - Pharmacological Reports
AU - Włodarczyk, Marcin
AU - Fichna, Jakub
AU - Sobolewska Włodarczyk, Aleksandra
PY - 2016
DA - 2016/08/01
PB - Springer Nature
SP - 797-801
IS - 4
VL - 68
PMID - 27162107
SN - 1734-1140
SN - 2299-5684
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2016_Włodarczyk,
author = {Marcin Włodarczyk and Jakub Fichna and Aleksandra Sobolewska Włodarczyk},
title = {Pharmacology and metabolism of infliximab biosimilars – A new treatment option in inflammatory bowel diseases},
journal = {Pharmacological Reports},
year = {2016},
volume = {68},
publisher = {Springer Nature},
month = {aug},
url = {https://doi.org/10.1016/j.pharep.2016.04.006},
number = {4},
pages = {797--801},
doi = {10.1016/j.pharep.2016.04.006}
}
Cite this
MLA
Copy
Włodarczyk, Marcin, et al. “Pharmacology and metabolism of infliximab biosimilars – A new treatment option in inflammatory bowel diseases.” Pharmacological Reports, vol. 68, no. 4, Aug. 2016, pp. 797-801. https://doi.org/10.1016/j.pharep.2016.04.006.